PRP therapy can slow the progression of osteoarthritis and protect your joints, offering a revolutionary approach to long-term pain relief and cartilage preservation.
Knee osteoarthritis (OA) is a leading cause of disability worldwide, affecting millions of people, particularly as they age.
In a significant development for osteoarthritis (OA) treatment, platelet-rich plasma (PRP) has received the designation of being “disease-modifying” for OA for nearly two years now.
As of 2024, platelet-rich plasma (PRP) therapy has firmly transitioned from being seen as experimental to a widely recognized treatment in orthopedics and sports medicine.
In the rapidly evolving field of biologic treatments, it's vital for patients to be aware of the regulatory landscape. Since June 2021, the FDA has set guidelines to ensure the safety and efficacy of biologic products.
Continuing our exploration of biologic injections, let's delve into some more essential considerations to ensure the effectiveness of your treatment.
Biologics have emerged as a promising avenue for treating various musculoskeletal issues, but it's crucial to ensure that the clinician administering these therapies is well-versed and up-to-date.
There is a lot of information in circulation about biologics and their respective treatment options. Here we’ll outline a few of the most important takeaways from this article series.
To see lasting effects from treatment using biologics—or more specifically Platelet-Rich Plasma (PRP) injections—we can’t overlook the importance of exercise.
Ready to schedule your first appointment?